Updated:
Recode Health Ventures
Recode Health Ventures is a venture capital firm dedicated exclusively to healthcare technology.
Recode Health Ventures
Recode Health Ventures is a venture capital firm dedicated exclusively to healthcare technology. Its founding team draws on experience from large healthcare organizations and startup scaling, but the firm has not publicly disclosed the names of its general partners or managing directors. The firm's strategy centers on early-stage investments — typically Seed through Series A — in companies building software platforms for providers, payers, and life sciences. The firm targets four primary asset-class areas: digital therapeutics, clinical workflow automation, payer technology (including prior authorization and revenue cycle management), and AI-driven diagnostics. Publicly confirmed portfolio companies include a small set of health IT startups; these are identified by SEC filings but the firm itself does not publish a portfolio list. The geographic focus is entirely within the United States, concentrated in the New York metro area and the broader Northeast corridor. Recode Health Ventures does not disclose AUM, number of professionals, or fundraising history. No additional offices beyond its New York headquarters have been confirmed. The firm has no known philanthropic foundation, operating company, or club membership that is publicly traceable. No verifiable material event from the last 24 months — such as a new fund close, personnel change, or exit — has been reported by a named publication. The firm's structural differentiator is its narrow sector mandate: unlike generalist venture firms that invest across multiple verticals, Recode Health Ventures limits itself entirely to healthcare. This constraint may give it deeper domain expertise in regulatory navigation and healthcare-specific go-to-market strategies, but the firm has not publicly demonstrated a unique sourcing model or co-investor network that distinguishes it from other emerging healthcare-only venture funds.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Recode Health Ventures?
Recode Health Ventures has not publicly identified the general partners or managing directors who lead investment decisions. Public records and official communications do not list any named principals for the firm. Institutional allocators should request a direct disclosure before proceeding with due diligence.
How does Recode Health Ventures source proprietary deal flow?
The firm has not publicly described its sourcing model. Given its narrow healthcare-sector focus, it likely relies on practitioner networks, industry conferences, and referrals from healthcare operators. However, no specific sourcing strategy has been disclosed in any known publication.
Is Recode Health Ventures structured as a venture firm or a family office?
The firm is classified as a venture capital firm in public filings. It has not disclosed whether it operates with single-family-office backing or institutional LP capital. The lack of public AUM data leaves this structural question unresolved.
Does Recode Health Ventures participate in fund commitments or only direct deals?
Recode Health Ventures appears to be a direct venture investor, not a fund-of-funds or secondary investor. There is no public record of the firm making commitments to external venture funds. It makes direct equity investments in early-stage healthcare technology companies.
What investment stages does Recode Health Ventures typically target?
Based on SEC filings and public signals, the firm targets Seed through Series A rounds. It has not disclosed an average check size or pre-money valuation range. The firm does not appear to be active in growth-stage (Series C and later) or crossover investments.
Which sectors does Recode Health Ventures explicitly avoid?
The firm is exclusively healthcare-focused and explicitly avoids non-healthcare sectors such as enterprise software, fintech, and consumer technology. Within healthcare, it avoids traditional life sciences (biotech, pharma) and medical device companies. It focuses on software-enabled services and platforms for providers, payers, and patients.
Where does the underlying wealth come from?
The source of the firm's capital has not been publicly disclosed. It is not known whether Recode Health Ventures is backed by a specific family fortune, institutional endowments, or high-net-worth individuals. The firm does not publish its investor base.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: